The economic burden of chronic kidney disease in the Russian Federation

Yagudina, R.; Serpik, V.G.; Abdrashitova, G.T.; Kotenko, O.N. Kotenko

doi:10.30809/phe.4.2014.5

Cited by 8 publications

(7 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Chronic kidney disease is one of the public health problem where 1 in 10 people estimated to be suffering from some form of kidney disorders. Report says 1,75,000 new cases of kidney failure(stage v CKD) comes up in India each year, severe enough to need dialysis [1]. The reported prevalence of CKD in different regions ranges from 1% to 13%, and recently, data from the International Society of Nephrology's Kidney Disease Data Center Study reported a prevalence of 17%.…”

Section: Epidemiologymentioning

confidence: 99%

“…In 2016: 417 million females and 336 million males. [1] In 2015 it caused 1.2 million deaths, up from 409,000 in 1990. [5] [6] The causes that contribute to the greatest number of deaths are high blood pressure at 550,000, followed by diabetes at 418,000, and glomerulonephritis at 238,000.…”

Section: Epidemiologymentioning

confidence: 99%

“…According to KDIGO (The Kidney Disease Improving Global Outcome) guidelines 2012 CKD is de ined "an abnormality of kidney function or structure, present for more than 3 months, with implications for health". CKD is classi ied based on, Glomerular Filtration Rates and albuminuria category [1][2][3].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Pharmacoeconomic evaluation of chronic kidney disease patients: a study on cost of illness

Y¹,

Esther²,

Sultana³

et al. 2020

ijprls

View full text Add to dashboard Cite

Chronic kidney diseases (CKD) is an important public health problem due to its high prevalence , morbidity and mortality. It is associated with high expenditure among indian patients. Higher stages of CKD have higher economic burden especially on the lower middle class. Hemodialysis, patients habits like alcohol consumption and smoking, treatment support by employer and patients with co morbid conditions and ESRD was found to effect the direct cost of the treatment.. Although CKD is generally Progressive and irreversible patients are advised regarding nutrition, life style changes and compliance with treatment might slow progression, enabling patients to live longer without complication and need for renal replacement therapy. Major barrier in the successful treatment of CKD is high cost of hemodialysis and medication which is difficult for the patient to afford. The main objective is to analyse the direct cost involved in treating Chronic Kidney disease patients in tertiary care hospital. Reimbursement, patients dialysis , social habits and comorbid conditions were found to have a significant effect on the direct cost of treatment.

show abstract

Section: Epidemiologymentioning

confidence: 99%

Section: Epidemiologymentioning

confidence: 99%

See 1 more Smart Citation

Pharmacoeconomic evaluation of chronic kidney disease patients: a study on cost of illness

Y¹,

Esther²,

Sultana³

et al. 2020

ijprls

View full text Add to dashboard Cite

show abstract

“…Ежегодно в РФ затраты на лечение пациентов с ХБП превышают 450 млрд рублей [2]. Это связано с дорогостоящим лечением больных ХБП, особенно на поздних стадиях заболевания, высокой инвалидизацией и смертностью, частыми госпитализациями в связи с сердечно-сосудистыми и церебральными осложнениями ХБП.…”

Section: Introductionunclassified

Specific risk factors for cerebrovascular disorders in patients with chronic kidney disease in the pre-dialysis period

Хрулёв

Никитина

Хрулёва

2019

Cardiovasc Ther Prev

View full text Add to dashboard Cite

Cerebral vascular disorders are one of the leading causes of disability and mortality in patients with chronic kidney disease (CKD). The article presents the currently available data on risk factors (RF) for the development of cerebrovascular disorders in pre-dialysis patients with CKD. Two groups of RF are identified: traditional and non-traditional (specific). Traditional RF, which include arterial hypertension, diabetes mellitus and hypercholesterolemia, independently affect the cerebral vascular bed and get worse against the background of CKD. Specific RF is associated with features of the CKD pathogenesis. It includes increased blood levels of homocysteine, β2-microglobulin, impaired calcium-phosphorus metabolism, accumulation of uremic toxins and toxins of intestinal bacteria, anemia and other factors. In the present review, special attention is paid to specific RF and pathogenetic mechanisms of the development of cerebrovascular disorders in predialysis patients with CKD. Timely detection of cerebral risk factors may lead to the improvement of early diagnosis and prevention of cerebral vascular disorders, optimization of therapy for patients with CKD.

show abstract

“…Taking into account the current situation in the RF, when the healthcare resources are limited and the cost of RRT is relatively high, optimization of the health care of end-stage renal disease patients from the viewpoint of the health care system is a priority task for the health care policy makers [16]. Pharmacoeconomic analysis is one of the important tools in choosing more clinically and economically effective therapy.…”

Section: Abstract: Chronic Kidney Disease End-stage Renal Replacemmentioning

confidence: 99%

Pharmacoeconomic analysis of medical care for chronic renal disease patients in need of renal replacement therapy via peritoneal dialysis and hemodialysis in the Russian healthcare environment

Abdrashitova¹,

Yagudina²,

Serpik³

2015

Pharmacoeconom T&P

Self Cite

View full text Add to dashboard Cite

The economic burden of chronic kidney disease in the Russian Federation

Cited by 8 publications

References 0 publications

Pharmacoeconomic evaluation of chronic kidney disease patients: a study on cost of illness

Pharmacoeconomic evaluation of chronic kidney disease patients: a study on cost of illness

Specific risk factors for cerebrovascular disorders in patients with chronic kidney disease in the pre-dialysis period

Pharmacoeconomic analysis of medical care for chronic renal disease patients in need of renal replacement therapy via peritoneal dialysis and hemodialysis in the Russian healthcare environment

Contact Info

Product

Resources

About